Clinical Researchs Most Recent Developments

Clinical research, an important sub-process in pharmaceutical R&D, offers faster returns on investment for pharmaceutical companies and better and safer patient care.

Fremont, CA: Pharmaceutical expenditures are one of the fastest-growing aspects of today's healthcare costs. Pharmaceutical R&D – the process of discovering, developing, and bringing new drug products to market – is a substantial cost driver.

Clinical Research Outsourcing

Companies outsourcing their clinical research activities is one of the primary developments from excessive expenses. Pharmaceutical corporations are altering the drug development services sector by outsourcing their R&D responsibilities. These service providers have evolved from a few small businesses providing limited clinical trial services to large multinational corporations providing a wide range of services such as preclinical evaluations, study design, clinical trial planning and management, independent safety data monitoring, biostatistical analysts, and more.

The Adoption of Electronic Records Facilitates Research.

Clinical research has been shifted to lower-cost places to respond to cost challenges. As a result, operating worldwide is becoming increasingly crucial for CROs. Globalizing clinical trials allows CROs to execute studies more efficiently and at reduced costs.

Adopting Electronic Records 

Another fast-growing trend is going paperless and increasing the use of electronic records. Hundreds of thousands of paper records are required for a typical new medication application. The adoption of electronic records has enhanced the success of other programs to lower the costs of development and data management in clinical research and make searching and analysis easier. Multiple technologies are used to enable electronic data capture and clinical trial administration systems for administrative data.

Creating a Unified Clinical Enterprise

Integrating the information silos from discovery to clinical development and commercialization is one of the most challenging difficulties facing the life sciences business. The next rising trend involves bringing data gathering, data management, data repository, and safety data together on a single platform and rethinking business processes and technologies within the company. Several prominent pharmaceutical companies are leading the way in this field. The processes of such initiatives revolve around developing clinical data standards (metadata) and parking the data in a clinical data repository and forming a team to govern and enforce the standards, as well as accessing the data from the warehouse for analysis and reporting, modeling, and simulation, and data pooling operations.